Randomized Study of Obicetrapib in Combination With Ezetimibe
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 112 participants.
Also called NCT04770389
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 112 participants
- Sponsor
- Registry
-
NCT04770389
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT04770389. Randomized; quadruple masking; primary purpose treatment. Start 2021-02-23 (actual); primary completion 2021-05-07 (actual). Results posted on 2024-04-24.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Randomized Study of Obicetrapib in Combination With Ezetimibe
- Acronym
- OCEAN
- Condition
- Dyslipidemias
- Condition
- High Cholesterol
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- Obicetrapib 5mg
- Intervention (Drug)
- Ezetimibe 10mg
- Intervention (Other)
- Placebo
- Lead sponsor
- NewAmsterdam Pharma
Record details
- Record id
cardio:ct-nct04770389- Content hash
d85f2e646d5fac8f7d0e2b1880f9ebf54abde2afd54ce6d8fb3ee86786ca9f67